JBC Journal of Breast Cancer

Original Article

The Incidence of Occult Malignancy in Contralateral Risk Reducing Mastectomy Among Affected Breast Cancer Gene Mutation Carriers in South Korea

Lee CE, Shin DS, Kim KJ, Nam SJ, Kim SW, Yu J, Chae BJ, Lee SK, Ryu JM, Mun GH, Pyon JK, Jeon BJ, Woo K, Lee JE.

Published online February 3, 2025
https://doi.org/10.4048/jbc.2024.0219

Original Article

Impact of HER2-Low Status on Pathologic Complete Response and Survival Outcome Among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Lee YJ, Yoo TK, Lee SB, Chung IY, Kim HJ, Ko BS, Lee JW, Son BH, Ahn SH, Jeong H, Jung JH, Ahn JH, Jung KH, Kim SB, Lee HJ, Gong G, Kim J.

Published online February 11, 2025
https://doi.org/10.4048/jbc.2024.0268

Original Article

Differences in HER2-0 and HER2-low Breast Cancer: Androgen Receptor and Programmed Death Ligand 1 as Predictive Factors

Zhang X, Yang C, Chen Y, Zhang J, Li P, Huang N, Chen Y, Liang M, Lv W, Yuan Z, Li J, Wang K.

Published online February 20, 2025
https://doi.org/10.4048/jbc.2024.0223

Brief Communication

Treatment Patterns and Outcomes of Young Female Early Breast Cancer in Taiwan

Huang CC, Tseng LM.

Published online January 24, 2025
https://doi.org/10.4048/jbc.2024.0188

Letter to the Editor

Letter to the Editor: “Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”

Bergmann A, de Andrade MF.

Published online January 24, 2025
https://doi.org/10.4048/jbc.2024.0286

Letter to the Editor

Reply to “Letter to the Editor: Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”

Byeon J, Kang E, Jung JJ, Cheun JH, Seo KS, Kim HK, Lee HB, Han W, Moon HG.

Published online February 3, 2025
https://doi.org/10.4048/jbc.2024.0299

Current Issue February 2025 • vol. 28 no. 1

Original Article

The Incidence of Occult Malignancy in Contralateral Risk Reducing Mastectomy Among Affected Breast Cancer Gene Mutation Carriers in South Korea

Lee CE, Shin DS, Kim KJ, Nam SJ, Kim SW, Yu J, Chae BJ, Lee SK, Ryu JM, Mun GH, Pyon JK, Jeon BJ, Woo K, Lee JE.

Published online February 3, 2025
https://doi.org/10.4048/jbc.2024.0219

Original Article

Impact of HER2-Low Status on Pathologic Complete Response and Survival Outcome Among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Lee YJ, Yoo TK, Lee SB, Chung IY, Kim HJ, Ko BS, Lee JW, Son BH, Ahn SH, Jeong H, Jung JH, Ahn JH, Jung KH, Kim SB, Lee HJ, Gong G, Kim J.

Published online February 11, 2025
https://doi.org/10.4048/jbc.2024.0268

Original Article

Differences in HER2-0 and HER2-low Breast Cancer: Androgen Receptor and Programmed Death Ligand 1 as Predictive Factors

Zhang X, Yang C, Chen Y, Zhang J, Li P, Huang N, Chen Y, Liang M, Lv W, Yuan Z, Li J, Wang K.

Published online February 20, 2025
https://doi.org/10.4048/jbc.2024.0223

Brief Communication

Treatment Patterns and Outcomes of Young Female Early Breast Cancer in Taiwan

Huang CC, Tseng LM.

Published online January 24, 2025
https://doi.org/10.4048/jbc.2024.0188

Letter to the Editor

Letter to the Editor: “Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”

Bergmann A, de Andrade MF.

Published online January 24, 2025
https://doi.org/10.4048/jbc.2024.0286

Letter to the Editor

Reply to “Letter to the Editor: Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”

Byeon J, Kang E, Jung JJ, Cheun JH, Seo KS, Kim HK, Lee HB, Han W, Moon HG.

Published online February 3, 2025
https://doi.org/10.4048/jbc.2024.0299

Forthcoming Articles

Past Issues

Submit Your
Manuscript to JBC

Editorial Manager®

JBC on

2023

Impact Factor 2.2

Oncology Q3

5-Year Impact Factor 2.2

Journal Citation Indicator Q3

JBC Review Time Period

Editor's Choice

•

The Incidence of Occult Malignancy in Contralateral Risk Reducing Mastectomy Among Affected Breast Cancer Gene Mutation Carriers in South Korea

•

Breast Cancer Statistics in Korea, 2021